This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages without signing in

Aspirin vs. low MW heparin for acute stroke in AF

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

DOUBLE-BLIND RANDOMISED STUDY

20% of all ischaemic strokes are caused by embolism due to atrial fibrillation. Patients with AF who have an ischaemic stroke are at a high risk of recurrent stroke.

This trial compared the efficacy of aspirin and low molecular weight heparin (LMWH) at preventing recurrent stroke within the first 14 days after the first stroke.

Reference:

  • 1) Berge, E, Abdelnoor, M. et al. (2000). Low molecular- weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. Lancet, 355, 1205-10.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.